Lab Test

Free PSA (including Total) for males 49 and younger

Test Codes

EPIC: LAB1232463, Beaker: QPSA T&F, Quest: 31348

Department

Send Outs

Instructions

Only performed on male patients at birth, who are 49 and younger.

Specimen Collection Criteria

Collect: One Red-top tube.
Also acceptable: One Gold-top SST tube.

Physician Office/Draw Specimen Preparation

Let serum specimens clot 30-60 minutes then immediately centrifuge to separate serum from cells. Transfer serum to plastic transport tube and freeze (-20°C/-4°F or below).

Preparation for Courier Transport

Transport: 2.0 mL serum, frozen (-20°C/-4°F or below). (Minimum: 0.6 mL)

Rejection Criteria

Specimens not collected and processed as indicated.

In-Lab Processing

Let serum specimens clot 30-60 minutes then immediately centrifuge to separate serum from cells. Transfer serum to plastic transport tube and freeze (-20°C/-4°F or below).

Transport: 2.0 mL serum, frozen (-20°C/-4°F or below). (Minimum: 0.6 mL)

Storage

Specimen Stability for Testing:

Room Temperature (20-26°C or 68-78.8°F): 72 hours
Refrigerated (2-8°C or 36-46°F): 72 hours
Frozen (-20°C/-4°F or below): 5 months

Specimen Storage in Department Prior to Disposal:

Specimen retention time is determined by the policy of the reference laboratory. Contact the Send Outs Laboratory with any questions.

Laboratory

Sent to Quest Diagnostics, Wood Dale, IL.

Performed

Monday – Friday.
Results available in 3 days.

Reference Range

PSA, Total

Male ≤4.0 ng/mL
Female Not established

PSA, Free See Laboratory Report

PSA, % Free
Male >25 % (calc)
Female Not established

Test Methodology

Immunoassay (IA)

Clinical Utility

PSA, Free and Total – In men over 50 years with total PSA between 4.0 and 10.0 ng/mL, the percent (%) free PSA gives an estimate of the probability of cancer. In these circumstances the measurement of the % free PSA may aid in avoiding unnecessary biopsies.

Elevated levels of Prostate Specific Antigen (PSA) have been associated with benign and malignant prostatic disorders. Studies indicate that in men 50 years or older measurement of PSA is a useful addition to the digital rectal exam in the early detection of prostate cancer. In addition, PSA decreases to undetectable levels following complete resection of the tumor and may rise again with recurrent disease or persist with residual disease. Thus, PSA levels may be of assistance in the management of prostate cancer patients.

CPT Codes

84153, 84154.

Contacts

Last Updated

10/30/2026

Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.